The SIGNAL Trial: Anti-semaphorin 4D Immunotherapy in Huntington's Disease

Neurology/Neurosurgery Grand Rounds

Friday, September 13, 2019 at 8:00 AM


Grand Round starts in:

HSC level 3, lecture hall 6 - Stony Brook, NY
September 13th, 2019
1.00 AMA PRA Category 1 Credit Hours

Description

A discussion on the SIGNAL Trial: anti-semaphorin 4D Immunotherapy in Huntington's disease

Dates and Times

Start: 9/13/2019 8:00 AM
End: 9/13/2019 9:00 AM

Objectives

  • To review the diagnosis and treatment of Huntington's disease
  • To provide an update on the status of a large ongoing multicenter clinical trial of a novel therapy for Huntington's disease (the SIGNAL trial)

Speakers

  • Dr. Andrew Feigin

Location

HSC level 3, lecture hall 6
Stony Brook Medicine
Stony Brook, NY 11794

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Give us a call
(631) 444-2094
Office of Continuing Medical Education
Renaissance School of Medicine at Stony Brook University
HSC, Level 2, Room 142
Stony Brook, New York 11794-8222